GOLIM4 protein, human

Known as: decapacitation factor 10, human, golgi phosphoprotein 4, human, golgi integral membrane protein 4, human

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2017

Sorting of Oligomerized Proteins: Implications in Toxin Trafficking and Quality Control

S. Venkat
2017
Corpus ID: 45697376

................................................................................................................................. 4 ACKNOWLEDGEMENTS .......................................................................................................... 6 INTRODUCTION ........................................................................................................................ 8 1.1 LYSOSOMAL DEGRADATION AS A MEANS OF GOLGI QUALITY CONTROL ............ 10 1.1.1 Integral membrane proteins ........................................................................................................ 10 1.1.2 Soluble proteins ................................................................................................................................. 15 1.1.3 Induced Oligomers ............................................................................................................................ 17 1.2 AUTOPHAGY AS A MEANS OF GOLGI QUALITY CONTROL .......................................... 23 1.3 PROTEASOMAL DEGRADATION AS A MEANS OF GOLGI QUALITY CONTROL ...... 26 1.4 CONCLUSION ............................................................................................................................. 27 MANGANESE-INDUCED TRAFFICKING AND TURNOVER OF GPP130 IS MEDIATED BY SORTILIN ..................................................................................................... 29 2.1 ABSTRACT ................................................................................................................................. 29 2.2 INTRODUCTION ....................................................................................................................... 30 2.3 RESULTS ..................................................................................................................................... 33 2.4 DISCUSSION ............................................................................................................................... 50 2.5 MATERIALS AND METHODS ................................................................................................. 54 CONCLUSIONS AND FUTURE DIRECTIONS .................................................................... 60 3.1 CONCLUSIONS ........................................................................................................................... 60 3.2 FUTURE DIRECTIONS ............................................................................................................. 63 REFERENCES ............................................................................................................................ 68

Highly Cited

1982

Highly Cited

1982

Sperm surface galactosyltransferase activities during in vitro capacitation